II. Mechanism

  1. Live attenuated virus Vaccine

III. Indications: Travel to Yellow Fever endemic areas

  1. Sub-Saharan Africa
  2. Amazon basin of South America

IV. Dose: Patient over age 9 months

  1. Dose: 0.5 ml subcutaneous every 10 years

V. Contraindications

  1. Immunocompromised Patient
    1. HIV Infection
    2. Immunosuppressive medications
  2. Pregnancy (relative contraindication)
  3. Infant under age 6 months
  4. Hypersensitivity to egg products

VI. Efficacy

  1. Effective in 100% of patients for 10 years

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window